Skip to content

13F-HR filed by Lepercq De Neuflize Asset Management LLC

Lepercq De Neuflize Asset Management LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-11, with 10 holding rows worth $151,585,875.

Accession
0001420506-25-001824
Filed
2025-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 10 entries on the cover page, a total value of $151,585,875 stated on the cover page (in dollars after the unit check, H1), rows summing to $151,585,875 with VALUE read as dollars as filed, 13F file number 028-25047. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS115,245$71,204,123dollars as filed
ISHARES TR464287465MSCI EAFE ETF466,000$41,655,740dollars as filed
SPDR S&P 500 ETF TR78462F953PUT60,000$37,071,000dollars as filedput
QORVO INC COM74736K101Stock13,700$1,163,267dollars as filed
XYLO TECHNOLOGIES LTD - SPON ADR58471G508COM26,059$132,385dollars as filed
CLARUS CORP NEW18270P109COM32,200$111,734dollars as filed
PRESIDIO PPTY TR INC74102L501COM CL A NEW14,412$75,375dollars as filed
WETOUCH TECHNOLOGY INC961881208COM NEW77,954$74,041dollars as filed
ESSA PHARMA INC29668H708COM NEW33,700$57,290dollars as filed
LAVA THERAPEUTICS NVN51517105SHS31,000$40,920dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-25-001824this filing2025-08-11acceptance time not in the bulk data set